Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04883502

Study of the Role of the Induced Membrane in the Reconstruction of Bone Loss in the Limbs

Status
Recruiting
Phase
Study type
Observational
Enrollment
80 (estimated)
Sponsor
Direction Centrale du Service de Santé des Armées · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Masquelet's induced membrane technique is a two-stage reconstructive surgery for severe bone fractures commonly used by military orthopedists. The particularity of this technique relies on the synthesis of a biological membrane induced by the transient implantation of a surgical cement (= 1st stage surgery). The presence of the induced membrane in the reconstruction space defines a microenvironment or "biological chamber" favourable to osteogenesis, positively influencing the repair of the lesion after implantation of an autologous bone graft (= 2nd stage of surgery). In view of the excellent clinical results obtained with this procedure, the Masquelet technique has gradually become a reference treatment in the field of orthopedic and trauma surgery. However, orthopedic surgeons sometimes observe failures in bone consolidation. To our knowledge, the role played by induced membrane in these therapeutic failures has never been studied.

Conditions

Interventions

TypeNameDescription
BIOLOGICALBlood sample collectionA blood sample will be collected at enrollment.
BIOLOGICALOther biological sample collectionThe following biological samples will be collected during the first surgery: * 1 blood sample * 3 fragments of induced membrane * 1 fragment of periosteum
DIAGNOSTIC_TESTSurgical waste collectionThe pieces of polymethylmethacrylate surgical cement will be collected during the second surgery.
DIAGNOSTIC_TESTRadiological examination and functional explorationA radiological examination and a functional exploration will be performed 6 weeks, 3 months and 6 months after the first surgery

Timeline

Start date
2021-10-29
Primary completion
2028-04-01
Completion
2028-04-01
First posted
2021-05-12
Last updated
2022-12-21

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT04883502. Inclusion in this directory is not an endorsement.